Hims & Hers (HIMS) stock has crash more than 25% in recent sessions after Novo Nordisk (NVO) filed a sweeping patent-infringement lawsuit targeting the company’s semaglutide offerings. This legal punch follows a U.S. Food Read More
00:05 Speaker A Time now for what to watch Wednesday, February 4th. We’re going to start off on the earnings front. Multiple big names on deck Wednesday including Uber and Qualcomm, but all eyes on Read More
Two more “Magnificent 7” companies are set to report in the week ahead, along other key players in tech, in another jam-packed week of earnings. Tech companies’ levels of capital expenditure has remained in the spotlight Read More